6533b871fe1ef96bd12d26f0
RESEARCH PRODUCT
Fermentation Products of Commensal Bacteria Alter Enterocyte Lipid Metabolism
Philippe J. SansonettiPhilippe J. SansonettiJoão R. AraújoSylvie DemignotSophie Vichier-guerreAsmaa TaziOdile Burlen-defranouxHélène LicandroGiulia Nigrosubject
[SDV.IMM] Life Sciences [q-bio]/ImmunologyEnterocyteBiologyGut floraMicrobiologyCell Linelipids03 medical and health sciences0302 clinical medicineLipid oxidationVirologyChylomicronsmedicineEscherichia coliAnimalsSecretionSymbiosis030304 developmental biology0303 health sciencescommensal bacteriaAMPKLipid metabolismMetabolismLacticaseibacillus paracaseiL-lactatebiology.organism_classificationLipid MetabolismCell biologyIntestinesMice Inbred C57BLmedicine.anatomical_structureEnterocytesFermentation[SDV.IMM]Life Sciences [q-bio]/ImmunologyParasitologyFemalelipids (amino acids peptides and proteins)acetatesmall intestine030217 neurology & neurosurgeryChylomicrondescription
eferred to byJia Wen, John F. RawlsFeeling the Burn: Intestinal Epithelial Cells Modify Their Lipid Metabolism in Response to Bacterial Fermentation ProductsCell Host & Microbe, Volume 27, Issue 3, 11 March 2020, Pages 314-316; International audience; Despite the recognized capacity of the gut microbiota to regulate intestinal lipid metabolism, the role of specific commensal species remains undefined. Here, we aimed to understand the bacterial effectors and molecular mechanisms by which Lactobacillus paracasei and Escherichia coli regulate lipid metabolism in enterocytes. We show that L-lactate produced by L. paracasei inhibits chylomicron secretion from enterocytes and promotes lipid storage by a mechanism involving L-lactate absorption by enterocytes, its conversion to malonyl-CoA, and the subsequent inhibition of lipid beta-oxidation. In contrast, acetate produced by E. coli also inhibits chylomicron secretion by enterocytes but promotes lipid oxidation by a mechanism involving acetate absorption by enterocytes, its metabolism to acetyl-CoA and AMP, and the subsequent upregulation of the AMPK/PGC-1α/PPARα pathway. Our study opens perspectives for developing specific bacteria- and metabolite-based therapeutic interventions against obesity, atherosclerosis, and malnutrition by targeting lipid metabolism in enterocytes.
year | journal | country | edition | language |
---|---|---|---|---|
2020-02-01 |